Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Exploring patient participation in reducing health-care-related safety risks
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Fig. 5.1. Number of medic<strong>in</strong>es per <strong>patient</strong> per day .................................................. 81<br />
Fig. 5.2. Relationship between <strong>patient</strong>s’ knowledge and the number of<br />
medic<strong>in</strong>es taken ................................................................................................ 82<br />
Fig. 5.3. Frequency with which doctors <strong>in</strong>quire about medication history .............. 83<br />
Fig. 5.4. Frequency with which <strong>patient</strong>s ask about <strong>in</strong>teractions between OTC<br />
and prescription medic<strong>in</strong>es ............................................................................... 83<br />
Fig. 5.5. Most important risk factors regard<strong>in</strong>g drug prescrib<strong>in</strong>g, accord<strong>in</strong>g to<br />
doctors.............................................................................................................. 84<br />
Fig. 5.6. Relationship between specialization and importance of risk factors .......... 85<br />
Fig. 5.7. Number of simultaneously taken medic<strong>in</strong>es for which the risk of<br />
<strong>in</strong>teraction is certa<strong>in</strong>, accord<strong>in</strong>g to doctors ....................................................... 86<br />
Fig. 5.8. Frequency of report<strong>in</strong>g ADRs to designated authorities by doctors’<br />
degree of specialization .................................................................................... 86<br />
Fig. 7.1. Patient experiences with <strong>safety</strong> management – <strong>in</strong><strong>patient</strong> hospital<br />
<strong>care</strong> <strong>in</strong> the Netherlands, 2009 .......................................................................... 128<br />
Fig. 7.2. Clients experienc<strong>in</strong>g competent and safe <strong>care</strong> – nurs<strong>in</strong>g homes and<br />
home <strong>care</strong> <strong>in</strong> the Netherlands, 2006 ................................................................. 129<br />
Fig. 7.3. In<strong>patient</strong> experiences <strong>in</strong> NHS hospitals, 2010 ........................................... 130<br />
Boxes<br />
Box 1.1. WHO Patient Safety Programme ............................................................. 2<br />
Box 4.1. Def<strong>in</strong>itions of adverse effects and <strong>in</strong>cidents <strong>in</strong> French law ........................ 51<br />
Box 4.2. List of questions asked dur<strong>in</strong>g expert <strong>in</strong>terviews ....................................... 58<br />
Box 4.3. Experts’ ma<strong>in</strong> suggestions to improve <strong>in</strong>formation provided to<br />
<strong>patient</strong>s on blood transfusion ........................................................................... 64<br />
Box 4.4. Experts’ ma<strong>in</strong> suggestions to <strong>in</strong>crease <strong>patient</strong> <strong>in</strong>volvement ........................ 66<br />
Box 6.1. Examples of <strong>in</strong>struments that help <strong>patient</strong>s to be <strong>in</strong>volved <strong>in</strong><br />
safe surgery ....................................................................................................... 108<br />
Box 7.1. “Patients for Patient Safety” – action area of the WHO World<br />
Alliance for Patient Safety ............................................................................... 119<br />
Box 7.2. Examples of degree and frequency foci <strong>in</strong> questions .................................. 123<br />
Box 8.1. The limits of the law .................................................................................. 144<br />
Box 8.2. Curricula and CME .................................................................................. 145<br />
Box 8.3. Public consumer <strong>in</strong>formation .................................................................... 146<br />
Box 8.4. Patient education ....................................................................................... 149<br />
Box A3.1. Report<strong>in</strong>g procedure ............................................................................... 157<br />
Box A3.2. Categories of reactions ............................................................................ 158<br />
vii